ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners for $490 million in cash, as the health technology company sharpens its focus on sleep, breathing and home-based care.
July 7 (Reuters) – ResMed (RMD.N), opens new tab said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners for $490 million in cash, as the health technology company sharpens its focus on slee… [335 chars]
Source: Reuters | Published: 2026-07-07T22:07:23Z
Credit: Reuters
